| Code | 9444D | ||||||||||
| MA number | 64/0007/22-S | ||||||||||
| Product Form: | int opo 3x3ml/0,9 mg+15 mg (fľ.LDPE+kvapkadlo) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Olikla s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle LDPE | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 17.02.2022 |
| Validity: | 17.02.2027 |
| Pediatric posology: | Yes |
| SPC: |
SPC_Bimatoprost timolol Olikla int opo_04.2023.pdf
|
| PIL: |
PIL_Bimatoprost timolol Olikla_int opo_04.2023.pdf
|
| Safety feature | Yes |
| Data update: | 29.06.2022 |
